Abnormal cells usually commit suicide, but cancer cells do not. There are a number of therapeutic antibodies that help kill cancer cells by binding to antigens expressed on the surface of cancer cells. This binding triggers a cell death process that leads to the eradication of the abnormal cells. Such antibodies are in high demand, but they are slow and expensive to produce.
A new research study from scientists in The Netherlands reports that one such antibody, called BR55-2, can now be derived from plants.
If the plant kingdom were to yield up more of these antibodies, the battle against cancer would have a significant new arsenal.
You can read the abstract by following the link below.
del.icio.us
Digg this
